Prognostic Value of Systemic Arterial Lactate Levels in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Major adverse caediac events
研究概览
简要总结
To assess the prognostic value of systemic arterial lactate levels in patients with ST segment elevation myocardial infarction undergoing primary PCI and correlate with the results of primary PCI and 30 days MACE follow up.
详细描述
- Study Population: STEMI patients treated with primary PCI.
- Study period: over 6 months.
- Sample Size: 300 patients.
All patients received the standard care for acute STEMI patients which is the primary percutaneous intervention in addition to medications.
Hyperlactemia is defined as elevated lactic acid level in the blood. The normal blood lactate level is (0.5-1 mmol/L).
All subjects were subjected to
- Careful history taking
- Full cardiac examination
- Investigations include:
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with ST-segment elevation myocardial infarction for the first time.
- •Patients undergoing primary PCI.
- •Adult patients ≥ 18 years old.
- •Exclusion criteria:
- •Hemodynamically unstable patients.
- •Patients with renal impairment (creatinine clearance < 30 ml/min).
- •Patients who developed flow limiting coronary dissection or mechanical complication during the procedure.
- •Patients presenting > 24 hours after symptoms onset.
排除标准
- 未提供
结局指标
主要结局
Major adverse caediac events
时间窗: 30 days
we follow up occurrence of death, reinfarction, repeated hospitalization and new onset heart failure
次要结局
未报告次要终点
研究者
Ahmed Hamdy Abdelhasseeb
clinical doctor
Ahmed Maher Teaching Hospital
